WALTHAM, Mass., Feb. 26, 2025 /PRNewswire/ -- Q32 Bio Inc. (Nasdaq: QTTB) ("Q32 Bio"), a clinical stage biotechnology company focused on developing biologic therapeutics to restore immune homeostasis, today announced that management will participate in two upcoming investor conferences in March:TD Cowen 45th Annual Health Care ConferenceDate: Wednesday, March 5, 2025Presentation Time: 11:50 a.m. E.T.Location: Boston, MALeerink Partners Global Healthcare ConferenceDate: Tuesday, March 11, 2025Fireside Chat P ...